Theravance Biopharma Stock Price History

Below is the normalized historical share price chart for Theravance Biopharma extending back to May 16, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Theravance Biopharma stands at 9.61, as last reported on the 21st of November, with the highest price reaching 9.97 and the lowest price hitting 9.59 during the day. If you're considering investing in Theravance Stock, it is important to understand the factors that can impact its price. Theravance Biopharma appears to be not too volatile, given 3 months investment horizon. Theravance Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.14, which indicates the firm had a 0.14% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Theravance Biopharma, which you can use to evaluate the volatility of the company. Please review Theravance Biopharma's Semi Deviation of 1.27, risk adjusted performance of 0.1231, and Coefficient Of Variation of 644.96 to confirm if our risk estimates are consistent with your expectations. As of now, Theravance Biopharma's Total Stockholder Equity is increasing as compared to previous years. The Theravance Biopharma's current Liabilities And Stockholders Equity is estimated to increase to about 454.6 M, while Common Stock Shares Outstanding is projected to decrease to under 53.3 M. . As of now, Theravance Biopharma's Price Fair Value is increasing as compared to previous years. Theravance Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1397

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns		TBPH
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

Expected Return

Risk-Adjusted Return